| Not Yet Recruiting | Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome Hypertension, Hypercortisolemia, Cushing Syndrome | Phase 4 | 2026-08-01 |
| Completed | Study in Healthy Subjects to Investigate the Relative Bioavailability and Safety of Pasireotide After Single S Pharmacokinetics, Safety | Phase 1 | 2025-12-01 |
| Active Not Recruiting | Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia Post-Bariatric Hypoglycemia | Phase 2 | 2024-01-04 |
| Unknown | Producing a Novel Symptom Burden Scale for People Living With Idiopathic Multicentric Castleman Disease (ISBUS Idiopathic Multicentric Castleman's Disease | — | 2023-10-01 |
| Completed | Osilodrostat for the Treatment of Non-Cushing's Disease Cushing's Syndrome Cushing's Syndrome | — | 2023-01-16 |
| Recruiting | An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics Hyperammonemia, Methylmalonic Acidemia, Propionic Acidemia | — | 2022-06-30 |
| Active Not Recruiting | Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome Endogenous Cushing's Syndrome | — | 2022-06-13 |
| Completed | Real-life Observational Study of Cancer Pain Management With Methadone Cancer Pain | — | 2022-02-21 |
| Recruiting | Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing Cushing Syndrome | Phase 2 | 2021-04-28 |
| Terminated | Siltuximab In Siltuximab-RElapsed/REfractory Multicentric CAstleman Disease Idiopathic Multicentric Castleman's Disease | Phase 2 | 2021-03-31 |
| Terminated | SILtuximab in Viral ARds (SILVAR) Study Acute Respiratory Distress Syndrome, Lung Diseases, Pneumonia | Phase 3 | 2020-11-13 |
| Completed | REC 0/0559 Eye Drops for Treatment of Moderate and Severe Neurotrophic Keratitis in Adult Patients Neurotrophic Keratitis | Phase 2 | 2020-10-13 |
| Completed | Cystadrops in Pediatric Cystinosis Patients From Six Months to Less Than Two Years Old (SCOB2) Cystinosis | Phase 3 | 2020-09-01 |
| Withdrawn | Real-life Study of Patients After 3-months of Leuprorelin 5mg Implant in Prostate Cancer Prostate Cancer | — | 2020-03-01 |
| Recruiting | Cold Agglutinin Disease Real World Evidence Registry Cold Agglutinin Disease (CAD), Cold Agglutinin Syndrome (CAS) | — | 2019-12-12 |
| Recruiting | A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuxim Neuroblastoma | — | 2019-09-30 |
| Recruiting | Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach Methylmalonic Acidemia, Propionic Acidemia | — | 2019-01-15 |
| Completed | Roll-over Study in Patients With Endogenous Cushing's Syndrome for LCI699 Cushing's Syndrome | Phase 2 | 2018-10-05 |
| Completed | Effects of Rec 0/0438 in Patients With Neurogenic Detrusor Overactivity Due to Spinal Cord Injury Neurogenic Detrusor Overactivity | Phase 1 / Phase 2 | 2018-06-07 |
| Completed | Interest of a Systematic Assessment of the Treatment of LUTS in the Management of BPH Benign Prostatic Hyperplasia | — | 2017-06-15 |
| Terminated | Efficacy and Safety of a Single TRUS-guided Intraprostatic Injection of NX-1207 in Patients With LUTS Due to B Lower Urinary Tract Symptoms | Phase 3 | 2013-09-01 |
| Completed | Study to Allow Access to Pasireotide for Patients Benefiting From Pasireotide Treatment in Novartis-sponsored Cushing's Disease, Acromegaly, Neuroendocrine Tumors | Phase 4 | 2013-06-10 |
| Completed | Long Term Safety and Efficacy of Pasireotide s.c. in Patients With Cushing's Disease Cushings Disease | — | 2013-03-28 |
| Completed | Evaluation of the Efficacy and Safety of Two Methadone Titration Methods for the Treatment of Cancer-related P Pain Related to Cancer | Phase 3 | 2012-01-05 |
| Completed | Effectiveness and Safety of Silodosin in the Treatment of Benign Prostatic Hyperplasia Benign Prostatic Hyperplasia | Phase 4 | 2011-05-01 |
| Completed | Efficacy and Safety of Lercanidipine and Enalapril in Patients With Essential Hypertension Essential Hypertension | Phase 2 | 2010-03-01 |
| Completed | Evaluation of the Efficacy and Safety of Silodosin in the Treatment of the Signs and Symptoms of BPH Benign Prostatic Hyperplasia | Phase 3 | 2006-05-01 |